A single center,retrospective study to evaluate the efficacy of Belatacept conversion from Tacrolimus on Glomerular filteration rate in patients with Kidney transplant
Latest Information Update: 31 Oct 2017
Price :
$35 *
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 26 Oct 2017 Primary endpoint has been met. (change in eGFR from the point of conversion to belatacept to 4 months post conversion (delta eGFR)) as per results published in the Transplantation
- 26 Oct 2017 Results published in the Transplantation
- 06 May 2017 New trial record